CYP26B1 and cancer: Differential expression analysis between benign and malignant tumors identified 14 significantly altered genes, including the downregulation of RPS26, LDLR, ST3GAL1, PHKA1 and VCAN, and upregulation of small nucleolar RNAs (SCARNA14, SNORA65) and CYP26B1.